Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)

Achille Iolascon, Maria D'Apolito, Veronica Servedio, Flora Cimmino, Antonio Piga, Clara Camaschella

Research output: Contribution to journalArticle

Abstract

Divalent metal transporter 1 (DMT1) mediates apical iron uptake in duodenal enterocytes and iron transfer from the transferrin receptor endosomal cycle into the cytosol in erythroid cells. Both mk mice and Belgrade rats, which carry an identical DMT1 mutation, exhibit severe microcytic anemia at birth and defective intestinal iron use and erythroid iron use. We report the hematologic phenotype of a child, compound heterozygote for 2 DMT1 mutations, who was affected by severe anemia since birth and showed hepatic iron overload. The novel mutations were a 3-bp deletion in intron 4 (c.310-3_5del CTT) resulting in a splicing abnormality and a C>T transition at nucleotide 1246(p. R416C). A striking reduction of DMT1 protein in peripheral blood mononuclear cells was demonstrated by Western blot analysis. The proband required blood transfusions until erythropoietin treatment allowed transfusion independence when hemoglobin levels between 75 and 95 g/L (7.5 and 9.5 g/dL) were achieved. Hematologic data of this patient at birth and in the first years of life strengthen the essential role of DMT1 in erythropoiesis. The early onset of iron overload indicates that, as in animal models, DMT1 is dispensable for liver iron uptake, whereas its deficiency in the gut is likely bypassed by the up-regulation of other pathways of iron use.

Original languageEnglish
Pages (from-to)349-354
Number of pages6
JournalBlood
Volume107
Issue number1
DOIs
Publication statusPublished - Jan 1 2006

Fingerprint

Iron Overload
Anemia
Iron
Mutation
Liver
Parturition
Erythroid Cells
Birth Order
Transferrin Receptors
Blood
Enterocytes
Erythropoiesis
Heterozygote
Erythropoietin
Blood Transfusion
Cytosol
Introns
solute carrier family 11- (proton-coupled divalent metal ion transporters), member 2
Blood Cells
Hemoglobins

ASJC Scopus subject areas

  • Hematology

Cite this

Iolascon, A., D'Apolito, M., Servedio, V., Cimmino, F., Piga, A., & Camaschella, C. (2006). Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood, 107(1), 349-354. https://doi.org/10.1182/blood-2005-06-2477

Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). / Iolascon, Achille; D'Apolito, Maria; Servedio, Veronica; Cimmino, Flora; Piga, Antonio; Camaschella, Clara.

In: Blood, Vol. 107, No. 1, 01.01.2006, p. 349-354.

Research output: Contribution to journalArticle

Iolascon, A, D'Apolito, M, Servedio, V, Cimmino, F, Piga, A & Camaschella, C 2006, 'Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)', Blood, vol. 107, no. 1, pp. 349-354. https://doi.org/10.1182/blood-2005-06-2477
Iolascon, Achille ; D'Apolito, Maria ; Servedio, Veronica ; Cimmino, Flora ; Piga, Antonio ; Camaschella, Clara. / Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). In: Blood. 2006 ; Vol. 107, No. 1. pp. 349-354.
@article{11c1b2a5e22d4cf0bf294cf74354bef4,
title = "Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)",
abstract = "Divalent metal transporter 1 (DMT1) mediates apical iron uptake in duodenal enterocytes and iron transfer from the transferrin receptor endosomal cycle into the cytosol in erythroid cells. Both mk mice and Belgrade rats, which carry an identical DMT1 mutation, exhibit severe microcytic anemia at birth and defective intestinal iron use and erythroid iron use. We report the hematologic phenotype of a child, compound heterozygote for 2 DMT1 mutations, who was affected by severe anemia since birth and showed hepatic iron overload. The novel mutations were a 3-bp deletion in intron 4 (c.310-3_5del CTT) resulting in a splicing abnormality and a C>T transition at nucleotide 1246(p. R416C). A striking reduction of DMT1 protein in peripheral blood mononuclear cells was demonstrated by Western blot analysis. The proband required blood transfusions until erythropoietin treatment allowed transfusion independence when hemoglobin levels between 75 and 95 g/L (7.5 and 9.5 g/dL) were achieved. Hematologic data of this patient at birth and in the first years of life strengthen the essential role of DMT1 in erythropoiesis. The early onset of iron overload indicates that, as in animal models, DMT1 is dispensable for liver iron uptake, whereas its deficiency in the gut is likely bypassed by the up-regulation of other pathways of iron use.",
author = "Achille Iolascon and Maria D'Apolito and Veronica Servedio and Flora Cimmino and Antonio Piga and Clara Camaschella",
year = "2006",
month = "1",
day = "1",
doi = "10.1182/blood-2005-06-2477",
language = "English",
volume = "107",
pages = "349--354",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)

AU - Iolascon, Achille

AU - D'Apolito, Maria

AU - Servedio, Veronica

AU - Cimmino, Flora

AU - Piga, Antonio

AU - Camaschella, Clara

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Divalent metal transporter 1 (DMT1) mediates apical iron uptake in duodenal enterocytes and iron transfer from the transferrin receptor endosomal cycle into the cytosol in erythroid cells. Both mk mice and Belgrade rats, which carry an identical DMT1 mutation, exhibit severe microcytic anemia at birth and defective intestinal iron use and erythroid iron use. We report the hematologic phenotype of a child, compound heterozygote for 2 DMT1 mutations, who was affected by severe anemia since birth and showed hepatic iron overload. The novel mutations were a 3-bp deletion in intron 4 (c.310-3_5del CTT) resulting in a splicing abnormality and a C>T transition at nucleotide 1246(p. R416C). A striking reduction of DMT1 protein in peripheral blood mononuclear cells was demonstrated by Western blot analysis. The proband required blood transfusions until erythropoietin treatment allowed transfusion independence when hemoglobin levels between 75 and 95 g/L (7.5 and 9.5 g/dL) were achieved. Hematologic data of this patient at birth and in the first years of life strengthen the essential role of DMT1 in erythropoiesis. The early onset of iron overload indicates that, as in animal models, DMT1 is dispensable for liver iron uptake, whereas its deficiency in the gut is likely bypassed by the up-regulation of other pathways of iron use.

AB - Divalent metal transporter 1 (DMT1) mediates apical iron uptake in duodenal enterocytes and iron transfer from the transferrin receptor endosomal cycle into the cytosol in erythroid cells. Both mk mice and Belgrade rats, which carry an identical DMT1 mutation, exhibit severe microcytic anemia at birth and defective intestinal iron use and erythroid iron use. We report the hematologic phenotype of a child, compound heterozygote for 2 DMT1 mutations, who was affected by severe anemia since birth and showed hepatic iron overload. The novel mutations were a 3-bp deletion in intron 4 (c.310-3_5del CTT) resulting in a splicing abnormality and a C>T transition at nucleotide 1246(p. R416C). A striking reduction of DMT1 protein in peripheral blood mononuclear cells was demonstrated by Western blot analysis. The proband required blood transfusions until erythropoietin treatment allowed transfusion independence when hemoglobin levels between 75 and 95 g/L (7.5 and 9.5 g/dL) were achieved. Hematologic data of this patient at birth and in the first years of life strengthen the essential role of DMT1 in erythropoiesis. The early onset of iron overload indicates that, as in animal models, DMT1 is dispensable for liver iron uptake, whereas its deficiency in the gut is likely bypassed by the up-regulation of other pathways of iron use.

UR - http://www.scopus.com/inward/record.url?scp=30144443274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30144443274&partnerID=8YFLogxK

U2 - 10.1182/blood-2005-06-2477

DO - 10.1182/blood-2005-06-2477

M3 - Article

C2 - 16160008

AN - SCOPUS:30144443274

VL - 107

SP - 349

EP - 354

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -